Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

6
Number of overlapping holdings
20.0%
% of PJP's 30 holdings also in PBE
21.4%
% of PBE's 28 holdings also in PJP
Overlap by Weight
Sector Drift (PJP minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PJP |
Weight in PBE |
Overlap | |
---|---|---|---|---|
GILEAD SCIENCES INC | 5.3% | 5.3% | 5.3% | |
AMGEN INC | 5.0% | 5.0% | 5.0% | |
COLLEGIUM PHARMACEUTICAL, INC. | 2.9% | 2.9% | 2.9% | |
BIOGEN IDEC INC | 2.5% | 4.7% | 2.5% | |
UNITED THERAPEUTICS CORP | 2.4% | 4.5% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
PJP Overweight Relative to PBE
ABBOTT LABORATORIES | 5.4% | |
JOHNSON & JOHNSON | 5.3% | |
ELI LILLY & CO | 5.3% | |
MERCK & CO. INC. | 4.8% | |
ABBVIE INC | 4.8% | |
PFIZER INC | 4.7% | |
BIOSANTE PHARMACEUTICALS INC | 3.9% | |
TARSUS PHARMACEUTICALS, INC. | 3.7% | |
CORCEPT THERAPEUTICS INC | 3.1% | |
INNOVIVA, INC. | 3.1% |
PJP Underweight Relative to PBE
NATERA INC | -5.4% | |
NEUROCRINE BIOSCIENCES INC | -4.9% | |
ILLUMINA INC | -4.2% | |
PROTAGONIST THERAPEUTICS, INC. | -4.1% | |
TG THERAPEUTICS INC | -4.0% | |
CATALYST PHARMACEUTICAL PART | -3.3% | |
HALOZYME THERAPEUTICS INC | -3.1% | |
EXELIXIS INC | -3.0% | |
ROYALTY PHARMA PLC CLASS A | -3.0% | |
PTC THERAPEUTICS INC | -2.9% |